• / Free eNewsletters & Magazine
  • / My Account
Home>Krystal Biotech seeks to raise up to $35 million in IPO

Krystal Biotech seeks to raise up to $35 million in IPO

3party Content

Tue, 22 Aug 2017

Krystal Biotech Inc. plans to raise up to $35 million in an initial public offering, according to a Securities and Exchange Commission filing late Monday. The Pittsburgh-based gene therapy company is a developer of treatments for dermatological diseases. With no revenue, Krystal reported a net loss

©2017 Morningstar Advisor. All right reserved.